176 related articles for article (PubMed ID: 34858479)
1. PPP1R14B Is a Prognostic and Immunological Biomarker in Pan-Cancer.
Deng M; Peng L; Li J; Liu X; Xia X; Li G
Front Genet; 2021; 12():763561. PubMed ID: 34858479
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive analysis of protein phosphatase 1 regulatory inhibitor subunit 14B, a molecule related to tumorigenesis, poor prognosis, and immune cell infiltration in lung adenocarcinoma.
Zheng YX; Shi S; Jiang XH; Liu KC; Qin ZJ; Wang YY; Li ZH; Chen MW
Am J Transl Res; 2023; 15(2):858-877. PubMed ID: 36915775
[TBL] [Abstract][Full Text] [Related]
3. SLMO2 is a potential prognostic and immunological biomarker in human pan-cancer.
Liu X; Yuan R; Peng J; Xu A; Nie X; Tang R; Li G
Sci Rep; 2024 Jan; 14(1):1070. PubMed ID: 38212657
[TBL] [Abstract][Full Text] [Related]
4. LncRNA PPP1R14B-AS1 Promotes Tumor Cell Proliferation and Migration via the Enhancement of Mitochondrial Respiration.
Yang Y; Zhang Y; Miao L; Liao W; Liao W
Front Genet; 2020; 11():557614. PubMed ID: 33262783
[TBL] [Abstract][Full Text] [Related]
5. Integrative transcriptome analysis identifies MYBL2 as a poor prognosis marker for osteosarcoma and a pan-cancer marker of immune infiltration.
Qiu X; He H; Zeng H; Tong X; Zhang C; Liu Y; Liao Z; Liu Q
Genes Dis; 2024 May; 11(3):101004. PubMed ID: 38292182
[TBL] [Abstract][Full Text] [Related]
6. Immunological Role and Prognostic Value of APBB1IP in Pan-Cancer Analysis.
Ge Q; Li G; Chen J; Song J; Cai G; He Y; Zhang X; Liang H; Ding Z; Zhang B
J Cancer; 2021; 12(2):595-610. PubMed ID: 33391455
[No Abstract] [Full Text] [Related]
7. The Prognostic Value and Immune Infiltration of USP10 in Pan-Cancer: A Potential Therapeutic Target.
Gao D; Zhang Z; Xu R; He Z; Li F; Hu Y; Chen H; Lu J; Cao X; Liu Y; Xu Z
Front Oncol; 2022; 12():829705. PubMed ID: 35433424
[TBL] [Abstract][Full Text] [Related]
8. The panoramic picture of pepsinogen gene family with pan-cancer.
Shen S; Li H; Liu J; Sun L; Yuan Y
Cancer Med; 2020 Dec; 9(23):9064-9080. PubMed ID: 33067881
[TBL] [Abstract][Full Text] [Related]
9. HILPDA Is a Prognostic Biomarker and Correlates With Macrophage Infiltration in Pan-Cancer.
Liu C; Zhou X; Zeng H; Wu D; Liu L
Front Oncol; 2021; 11():597860. PubMed ID: 33816230
[No Abstract] [Full Text] [Related]
10. C1QTNF6 is a Prognostic Biomarker and Related to Immune Infiltration and Drug Sensitivity: A Pan-Cancer Analysis.
Liu W; Zhang J; Xie T; Huang X; Wang B; Tian Y; Yuan Y
Front Pharmacol; 2022; 13():855485. PubMed ID: 35401204
[No Abstract] [Full Text] [Related]
11. Systematic Pan-Cancer Analysis Identifies TREM2 as an Immunological and Prognostic Biomarker.
Cheng X; Wang X; Nie K; Cheng L; Zhang Z; Hu Y; Peng W
Front Immunol; 2021; 12():646523. PubMed ID: 33679809
[TBL] [Abstract][Full Text] [Related]
12. Integrative analysis of WDR12 as a potential prognostic and immunological biomarker in multiple human tumors.
Eid RA; Eldeen MA; Soltan MA; Al-Shraim M; Aldehri M; Alqahtani LS; Alsharif G; Albogami S; Jafri I; Fayad E; Park MN; Bibi S; Behairy MY; Kim B; Zaki MSA
Front Genet; 2022; 13():1008502. PubMed ID: 36726716
[No Abstract] [Full Text] [Related]
13. Zinc finger C3H1-type containing serves as a novel prognostic biomarker in human pan-cancer.
Liang W; Chen W; Wei J; Yao H; Shi J; Hou X; Deng Y; Ou M
Gene; 2022 Apr; 820():146251. PubMed ID: 35131366
[TBL] [Abstract][Full Text] [Related]
14. Pan-Cancer Analysis of Immune Cell Infiltration Identifies a Prognostic Immune-Cell Characteristic Score (ICCS) in Lung Adenocarcinoma.
Zuo S; Wei M; Wang S; Dong J; Wei J
Front Immunol; 2020; 11():1218. PubMed ID: 32714316
[No Abstract] [Full Text] [Related]
15. HMMR potential as a diagnostic and prognostic biomarker of cancer-speculation based on a pan-cancer analysis.
Shang J; Zhang X; Hou G; Qi Y
Front Surg; 2022; 9():998598. PubMed ID: 36704516
[TBL] [Abstract][Full Text] [Related]
16. Genome-wide association studies identify miRNA-194 as a prognostic biomarker for gastrointestinal cancer by targeting ATP6V1F, PPP1R14B, BTF3L4 and SLC7A5.
Huang P; Xia L; Guo Q; Huang C; Wang Z; Huang Y; Qin S; Leng W; Li D
Front Oncol; 2022; 12():1025594. PubMed ID: 36620589
[TBL] [Abstract][Full Text] [Related]
17. FAM65A as a novel prognostic biomarker in human tumors reveal by a pan-cancer analysis.
Liang W; Mo C; Wei J; Chen W; Gong W; Shi J; Hou X; Li C; Deng Y; Ou M
Discov Oncol; 2021 Dec; 12(1):60. PubMed ID: 35201499
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value and immunological role of PDCD1 gene in pan-cancer.
Miao Y; Wang J; Li Q; Quan W; Wang Y; Li C; Wu J; Mi D
Int Immunopharmacol; 2020 Dec; 89(Pt B):107080. PubMed ID: 33069926
[TBL] [Abstract][Full Text] [Related]
19. A pan-cancer analysis reveals CHD1L as a prognostic and immunological biomarker in several human cancers.
Soltan MA; Eldeen MA; Eid RA; Alyamani NM; Alqahtani LS; Albogami S; Jafri I; Park MN; Alsharif G; Fayad E; Mohamed G; Osman R; Kim B; Zaki MSA
Front Mol Biosci; 2023; 10():1017148. PubMed ID: 37033447
[No Abstract] [Full Text] [Related]
20. KIF18B is a Prognostic Biomarker and Correlates with Immune Infiltrates in Pan-Cancer.
Qiu MJ; Wang QS; Li QT; Zhu LS; Li YN; Yang SL; Xiong ZF
Front Mol Biosci; 2021; 8():559800. PubMed ID: 34109209
[No Abstract] [Full Text] [Related]
[Next] [New Search]
